These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1996087)

  • 1. A stem cell-specific silencer in the primer-binding site of a retrovirus.
    Petersen R; Kempler G; Barklis E
    Mol Cell Biol; 1991 Mar; 11(3):1214-21. PubMed ID: 1996087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site.
    Kempler G; Freitag B; Berwin B; Nanassy O; Barklis E
    Virology; 1993 Apr; 193(2):690-9. PubMed ID: 8460481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell factor binding to retrovirus primer binding site silencers.
    Yamauchi M; Freitag B; Khan C; Berwin B; Barklis E
    J Virol; 1995 Feb; 69(2):1142-9. PubMed ID: 7529329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells.
    Loh TP; Sievert LL; Scott RW
    Mol Cell Biol; 1990 Aug; 10(8):4045-57. PubMed ID: 2370861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells.
    Haas DL; Lutzko C; Logan AC; Cho GJ; Skelton D; Jin Yu X; Pepper KA; Kohn DB
    J Virol; 2003 Sep; 77(17):9439-50. PubMed ID: 12915559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells.
    Loh TP; Sievert LL; Scott RW
    Mol Cell Biol; 1987 Oct; 7(10):3775-84. PubMed ID: 3683398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
    Feuer G; Taketo M; Hanecak RC; Fan H
    J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.
    Grez M; Zörnig M; Nowock J; Ziegler M
    J Virol; 1991 Sep; 65(9):4691-8. PubMed ID: 1870196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
    Feuer G; Fan H
    J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
    Fan H; Mittal S; Chute H; Chao E; Pattengale PK
    J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of high affinity cellular targets of the embryonal LTR binding protein, an undifferentiated embryonal carcinoma cell-specific repressor of Moloney leukemia virus.
    Tsukiyama T; Niwa O
    Nucleic Acids Res; 1992 Apr; 20(7):1477-82. PubMed ID: 1579438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
    Overhauser J; Fan H
    J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells.
    Linney E; Davis B; Overhauser J; Chao E; Fan H
    Nature; 1984 Mar 29-Apr 4; 308(5958):470-2. PubMed ID: 6323996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells.
    Tsukiyama T; Niwa O; Yokoro K
    J Virol; 1991 Jun; 65(6):2979-86. PubMed ID: 2033663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites.
    Basu S; Varmus HE
    J Virol; 1990 Nov; 64(11):5617-25. PubMed ID: 2214028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain.
    Loh TP; Sievert LL; Scott RW
    J Virol; 1988 Nov; 62(11):4086-95. PubMed ID: 3172339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
    Hanecak R; Pattengale PK; Fan H
    J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrovirus activation in embryonal carcinoma cells by cellular promoters.
    Peckham I; Sobel S; Comer J; Jaenisch R; Barklis E
    Genes Dev; 1989 Dec; 3(12B):2062-71. PubMed ID: 2628163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
    Granger SW; Fan H
    J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. tRNA isoacceptor preference prior to retrovirus Gag-Pol junction links primer selection and viral translation.
    Palmer MT; Kirkman R; Kosloff BR; Eipers PG; Morrow CD
    J Virol; 2007 May; 81(9):4397-404. PubMed ID: 17301132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.